New Bracco Imaging and Arrayus Technologies Partnership Bracco Imaging partners with Arrayus Technologies to advance drug delivery for pancreatic cancer using focused ultrasound and microbubble technology.

How AI Is Revolutionizing Medical Writing Explore how AI is transforming medical writing, streamlining workflows, and improving accuracy in clinical documentation for healthcare providers.

Gadopiclenol Wins JFR 2024 Innovation Award Bracco’s gadopiclenol earns the JFR 2024 Innovation Award for its breakthrough role in improving MRI imaging quality and patient safety standards.

Bracco Diagnostics Inc. Achieves 1 Million Injections with VUEWAY® (gadopiclenol) solution for injection Bracco Diagnostics Inc. is proud to announce that its most recently FDA-approved magnetic resonance imaging (MRI) agent, VUEWAY® (gadopiclenol) solution for injection, has reached over one million patient injections at over 480 customer sites.

Bracco AiMIFY™ Receives FDA Clearance Bracco announces FDA clearance for AiMIFY™ software, improving efficiency in molecular imaging interpretation and workflow.

Bracco Innovations Featured at RSNA 2024 Explore the advanced diagnostic imaging solutions Bracco presented at RSNA 2024, including contrast agents, injectors, and AI-driven tools.

Bracco triples production of its innovative ultrasound contrast agent in Geneva Over 80 million euros has been invested to build Hexagon, a new manufacturing facility located next to the historical 1996 plant which will, when fully operational, triple the production and distribution of one of the leading products from Bracco's research.

EuSoMII and Bracco together for the 2nd AI Contest One year is gone and we are back in Pisa. It’s the 10th (and 11th) of October 2024, and the EuSoMII, is hosting its annual meeting that brings together people with different backgrounds and expertise from the world of radiology. 

ColoWatch® and Bracco Diagnostics Partner to Expand the Availability of Virtual Colonoscopy for the Early Detection of Colon and Rectal Cancer To learn more, visit Bracco’s booth #3300 at the Radiological Society of North America (RSNA) 2024 Annual Meeting, to be held from December 1-5 in Chicago, Illinois

Webinar: Effective Gadolinium Reduction with the New High- Relaxivity Gadopiclenol in CNS We are pleased to invite you to join an educational webinar entitled Effective Gadolinium Reduction with the New High- Relaxivity Gadopiclenol in CNS scheduled for January 15 from 6:00 to 7:00 pm CET.